Popular Stories

COVID-19 Tag

  • All
  • Biotechnology
  • Cannabis
  • Education
  • Investing Ideas
  • Macro
  • Miscellaneous
  • Sectors
  • Startups
  • Technologies
  • Trending
  • Uncategorized
3 Growth Stocks to Watch In 2021!

T2 Biosystems, Inc. recently announced that its T2SARS-CoV-2™ Panel, a molecular diagnostic test that detects SARS-CoV-2, can detect the Brazil (P.1) variant of the SARS-CoV-2 virus. This expands the utility of its panel to reliably detect newer variants that have emerged in United Kingdom (B.1.1.7)...

3 Stocks To Watch in 2021!

TherapeuticsMD (NASDAQ: TXMD), is a women’s healthcare Company focused on creating novel solutions for challenges encountered by women in areas such as family planning, reproductive health, and menopause management. The Company’s product offerings include Annovera, a progestin/estrogen CHC vaginal birth control ring intended for contraception,...

Sorrento could be the next breakout stock. Find out why!

Sorrento Therapeutics, Inc. (NASDAQ: SRNE) is in the spotlight after receiving a “Buy” rating along with a $30 price target from Ram Selvaraju an analyst at H.C Wainwright, implying a nearly 275% upside from its current levels. We take a look at reasons for the...

BioSig Makes A “Smart” Move, Partners with Vuzix®Corp

BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device Company leveraging its signal processing technology platform, announced its partnership with Vuzix® Corporation (NASDAQ: VUZI), to deploy Vuzix’s M400 Smart Glasses for remote servicing, installations, upgrades and training of its  PURE EP™ System, to support a nationwide...

3 Diagnostic Companies Riding the Wave of Pandemic

The Pandemic has had a tremendous impact on the Diagnostics Industry, with increased demand for stringent testing across the world. According to a report by Research and Markets, the Global in-vitro diagnostics market is expected to reach USD 96.0 billion by 2025, growing at a CAGR of...

Can Novan Nitric Oxide Based Approach pay off in the long run?

Novan, Inc. (NASDAQ: NOVN), a clinical–stage Biotechnology Company leveraging its expertise in nitric oxide-based therapies, has entered into a Master Services Agreement (MSA) with Catalent for supporting the development and chemistry, manufacturing and control (CMC) activities for berdazimer sodium, to be made into an intranasal...

WordPress Video Lightbox Plugin